What RedHill Biopharma Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 2 |
| Total trades | 1 | 2 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Raday Gilead | Chief Operating Officer | Jul 10 | Sale for tax withholding · S | −14,130,000 | $0.00 | −$1.41K | 218,780,000 |
| Raday Gilead | Chief Operating Officer | Apr 06 | Sale for tax withholding · S | −15,740,000 | $0.00 | −$1.57K | 261,060,000 |
Loading...
